Patients infected with hepatitis C virus (HCV) have an increased risk of developing type 2 diabetes. HCV infection is linked to various liver abnormalities, potentially contributing to this association. We show that HCV infection increases the levels of hepatic selenoprotein P (SeP) mRNA (SEPP1 mRNA) and serum SeP, a hepatokine linked to insulin resistance. SEPP1 mRNA inhibits type I interferon responses by limiting the function of retinoic-acid-inducible gene I (RIG-I), a sensor of viral RNA. SEPP1 mRNA binds directly to RIG-I and inhibits its activity. SEPP1 mRNA knockdown in hepatocytes causes a robust induction of interferon-stimulated genes and decreases HCV replication. Clinically, high SeP serum levels are significantly associated with treatment failure of direct-acting antivirals in HCV-infected patients. Thus, SeP regulates insulin resistance and innate immunity, possibly inducing immune tolerance in the liver, and its upregulation may explain the increased risk of type 2 diabetes in HCV-infected patients.
Pubmed ID: 30974086 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
THIS RESOURCE IS NO LONGER IN SERVICE. Documented on May 5,2022.Tool that predicts interactions between transcription factors and their regulated genes from binding motifs. Understanding vertebrate development requires unraveling the cis-regulatory architecture of gene regulation. PRISM provides accurate genome-wide computational predictions of transcription factor binding sites for the human and mouse genomes, and integrates the predictions with GREAT to provide functional biological context. Together, accurate computational binding site prediction and GREAT produce for each transcription factor: 1. putative binding sites, 2. putative target genes, 3. putative biological roles of the transcription factor, and 4. putative cis-regulatory elements through which the factor regulates each target in each functional role.
View all literature mentionsThis polyclonal secondary targets IgG
View all literature mentionsThis polyclonal targets IgG
View all literature mentionsThis monoclonal targets Influenza A Virus Nucleoprotein antibody [C43]
View all literature mentionsThis monoclonal targets GST (91G1) Rabbit mAb
View all literature mentionsThis polyclonal targets DYKDDDK
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis monoclonal targets His-Tag
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis monoclonal targets C/EBPalpha (D56F10) XP Rabbit mAb
View all literature mentionsThis polyclonal targets COX IV
View all literature mentionsThis monoclonal targets IRF3
View all literature mentionsThis monoclonal targets LDHA
View all literature mentionsThis polyclonal targets RPS27A
View all literature mentionsThis monoclonal targets MDA-5 (D74E4) Rabbit mAb
View all literature mentionsThis monoclonal targets Rig-I
View all literature mentionsThis monoclonal targets Phospho-IRF-3 (Ser396)
View all literature mentions